This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The extracellular signal molecule autoinducer-2 (AI-2) mediates quorum sensing communication in diverse bacterial species. In marine vibrios, binding of AI-2 to the periplasmic receptor LuxP modulates the activity of the inner membrane sensor kinase LuxQ, transducing the AI-2 information into the cytoplasm. At low cell density, when LuxP is not bound to AI-2, LuxQ functions as a kinase, whereas at high cell density, when LuxP is bound to AI-2, LuxQ acts as a phosphatase. We have shown that Vibrio harveyi LuxP associates constitutively with LuxQ in both the presence and absence of AI-2. The 1.9 ¿¿¿ x-ray crystal structure of apoLuxP, complexed with the periplasmic domain of LuxQ, reveals that the latter contains two tandem PAS (Per/ARNT/Simple-minded) folds. Thus, although many prokaryotic PAS folds themselves bind ligands, the LuxQ periplasmic PAS folds instead bind LuxP, monitoring its AI-2 occupancy. Mutations that disrupt the apoLuxP:LuxQ interface sensitize V. harveyi to AI-2, implying that AI-2 binding causes the replacement of one set of LuxP:LuxQ contacts with another. These conformational changes switch LuxQ between two opposing enzymatic activities, each of which conveys information to the cytoplasm about the cell density of the surrounding environment. Comparison of the apo complex and holo complex (proposed here) structures will reveal AI-2-induced conformational changes, and therefore, the mechanism of AI-2 signaling regulation.
Bacteria modulate gene expression in response to changes in cell density via a mechanism termed quorum sensing. This density-triggered response results in coordinated phenotypic changes within bacterial populations. Quorum sensing directs processes including virulence factor expression, biofilm development, bioluminescence, antibiotic production, and DNA exchange. Our studies will facilitate the rational design of broad-spectrum antibacterial compounds that interfere with quorum sensing. Discovery of such compounds is critical as bacteria increasingly become resistant to current antimicrobial therapies.
Public Health Relevance Statement
Data not available.
NIH Spending Category
Biotechnology
Project Terms
Anti-Bacterial AgentsAntibioticsBacteriaBindingBioluminescenceCell DensityCommunicationComplexComputer Retrieval of Information on Scientific Projects DatabaseCrystallographyCytoplasmDNADevelopmentEnvironmentFundingGene ExpressionGrantInstitutionLigand BindingLightMarinesMediatingMembraneMicrobial BiofilmsMindMonitorMutationPhosphoric Monoester HydrolasesPhosphotransferasesPopulationProcessProductionRegulationResearchResearch PersonnelResistanceResourcesSignal TransductionSignaling MoleculeSourceStructureSynchrotronsUnited States National Institutes of HealthVAI-2VibrioVirulence Factorsantimicrobialdensitydesignextracellularperiplasmquorum sensingreceptorresponsesensor
No Sub Projects information available for 5P41RR012408-13 7539
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR012408-13 7539
Patents
No Patents information available for 5P41RR012408-13 7539
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR012408-13 7539
Clinical Studies
No Clinical Studies information available for 5P41RR012408-13 7539
News and More
Related News Releases
No news release information available for 5P41RR012408-13 7539
History
No Historical information available for 5P41RR012408-13 7539
Similar Projects
No Similar Projects information available for 5P41RR012408-13 7539